Our Focus
Newormics offers advanced microfluidic devices for high-throughput and high-content screening of small animal models and 3D tissue organoids.
We also provide toxicology services and solutions.
We also provide toxicology services and solutions.
OUR TEAM
We are a team of innovators from Austin in the fields of microfluidics, life-science imaging, and chemical screening.
Adela Ben-Yakar, PhD
Chief Executive Officer, Co-Founder
A professor with dual appointments in Mechanical Engineering and Biomedical Engineering at The University of Texas at Austin, Dr Ben Yakar’s research focuses on the creation of imaging technologies and novel laser surgery with high precision. Educated at Stanford and the Technion in Israel, with post-doctoral study at Harvard, and using her NIH Director’s Transformative Research Award, Dr Ben Yakar began the research that has culminated in the launch of Newormics, LLC.
Evan Hegarty
Dir. of Manufacturing, Co-Founder
Evan Hegarty, co-founder, received his M.S. in Mechanical Engineering at The University of Texas at Austin while developing the technology and IP that lead to the launch of Newormics, LLC. As the Director of Manufacturing and Product development, and Principal Investigator of NIH SBIR grants at Newormics, Evan is responsible for development of all chip and system designs, creating production schedules, optimizing production methods, managing team members, identifying customer needs, developing future products, and reinforcing GLP and GMP.
Adam Laing, PHD
Scientist
Dr. Adam Laing is a molecular and cellular biologist educated at the University of Edinburgh, and leads the Research and Development activities of Newormics. He is responsible for testing and characterizing the new devices and imaging methods, and development of toxicology and drug screening assays in C. elegans as well as tissue organoids.
Shivang Sharma
Tech. Sales and Marketing Manager
Shivang is a Biomedical Engineer, with sales & business acumen. He is heading our Sales & Marketing team and is responsible for customer relationship management, developing, maintaining and identifying KOLs, along with developing new product pricing strategies. He is also responsible for organizing marketing, media events, product promotional activities at conferences and B2B sales plans.
Gina Lento, PhD
Business Advisor
Dr. Lento is a serial COO/VPO executive for life science startups with broad skills in pharmaceuticals, medical devices, and diagnostics. With a unique background of equal parts government, public and private sector service, Dr. Lento’s holds a PhD in Biochemistry and additional credentials in Drug Evaluation, Pharmaceutical Sciences, and Corporate Governance.
LATEST NEWS
DDNews features Newormics in their latest issue in a special report on drug screening
The research of Newormics is featured in a special report in the July 2019 issue of DDNews in an article titled “Phenotypic finery: Microscopy meets the molecular in the search for phenotypic impacts in drug screening”.
Newormics at the 2019 UK C. elegans meeting
Newormics is exhibiting at the 2019 UK C. elegans meeting at Imperial College London on September 16th. Come meet us and view our latest imaging solutions there.
Newormics at the 2019 International C. elegans meeting
Newormics is exhibiting at the 22nd International C. elegans Conference at UCLA, Los Angeles from 20th June – 24th June. Come and meet the team here at our booth.